The short answer
L-arginine lowered blood pressure in one small hypertension subgroup, but extra low-blood-pressure risk with prazosin has not been demonstrated. Review the dose and symptoms before adding it.
What this answer covers
Oral prazosin and supplemental L-arginine; oral gram-dose studies, not IV arginine or dietary protein.
- Supplement or preparation
- L-Arginine
- Medication ingredient
- prazosin
What oral studies show
In a four-week study, significant BP lowering occurred only in the hypertensive subgroup receiving 12 g daily. A report of 19 healthy participants found no significant BP reduction at 6 or 12 g daily. The healthy participants may overlap the companion study, so these are not independent confirmations.
What remains unknown
Neither report establishes the effect of combining L-arginine with prazosin, whether symptomatic low pressure becomes more frequent, or a safe supplement dose for that combination. An average reduction in a hypertension study is different from harmful fainting in an individual.
Plan use around your clinical needs
Tell the prescriber the daily gram amount, reason for taking it and other ingredients. The studied amounts are not dosing recommendations. Do not reduce prazosin or rely on a spacing interval from these trials; treatment decisions should use your pressure readings and symptoms.
Respond to symptoms
Prazosin can cause dizziness, lightheadedness or fainting, particularly when treatment begins or the dose changes. Report troublesome symptoms to the prescriber; sit or lie down if you feel faint and avoid hazardous activity while affected. A blood-pressure reading and the timing of symptoms can help distinguish a medication effect from an unproven supplement interaction.
Evidence and practical considerations
Side effects & toxicity
Oral L-arginine BP findings are dose- and population-dependent and do not prove excess hypotension with prazosin.
- Exact scope
- Oral prazosin and supplemental L-arginine; oral gram-dose studies, not IV arginine or dietary protein. with Current RxNorm confirms prazosin RxCUI 8629 IN. Hydrochloride polyhydrate capsules provide the equivalent of prazosin 1, 2 or 5 mg. Oral formulation only.
- Medication form and route
- Oral
What remains uncertain
- Abstract-only oral studies; no exact combination, clinical hypotension or validated timing data.
Factors that may matter: Exact preparation and dose; Blood pressure and symptoms; Treatment initiation or dose change; Other medicines.
Read the supporting source summaries
Source 1: Current prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed prazosin hydrochloride capsules.
Postural hypotension, fainting and drowsiness can occur, particularly with initiation, dose escalation or additional BP-lowering medication.
How this applies: Exact ingredient through the stated labeled salt and oral formulation. Current RxNorm confirms prazosin RxCUI 8629 IN. Hydrochloride polyhydrate capsules provide the equivalent of prazosin 1, 2 or 5 mg. Oral formulation only.
No botanical interaction established merely by these drug-alone warnings.
Source 2: Original clinical research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 54 completing participants, including 35 with mild hypertension and 19 healthy controls.
Significant ambulatory BP reduction only in the 12 g/day hypertensive subgroup.
How this applies: Exact preparation and endpoint boundaries retained; this is not a measured prazosin combination unless explicitly stated.
Abstract-only; no prazosin co-use or demonstrated symptomatic hypotension. Not a recommended dose.
Source 3: Original clinical research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 19 healthy adults.
BP decreases were not statistically significant.
How this applies: Exact preparation and endpoint boundaries retained; this is not a measured prazosin combination unless explicitly stated.
Abstract-only; healthy population. May overlap the healthy cohort of the companion study, so not counted as independent replication.
Source 4: Medication terminology
rxnav.nlm.nih.gov · Source check Sep 10, 2026
Population: Terminology.
prazosin is IN.
How this applies: Exact ingredient.
Not clinical evidence.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Sources checked and article drafted. | |
| Research summary published |
Article revision: abca50eee95a4117
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.